TrialCancer2018

Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131.

Wanda L Salzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.